Iceland· IS-EU/1/22/1703/001
Pluvicto
A lutetium (177lu) oxodotreotide product containing lutetium (177lu) vipivotide tetraxetan, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Lutetium (177lu) oxodotreotide is registered in 11 of 19 countries.
Countries holding a registration under ATC V10XX04 (lutetium (177lu) oxodotreotide), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Lutetium (177lu) oxodotreotide · ATC V10XX04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Lutetium (177Lu) vipivotide tetraxetan
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- V10XX04
- ATC class
- Lutetium (177Lu) oxodotreotide
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (177lu) oxodotreotide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPLUVICTONovartis Europharm Limited, Dublin
- FinlandPluvictoNovartis Europharm Limited
- SwitzerlandPluvicto 1000 MBq/ml, Injektions-/InfusionslösungNovartis Pharma Schweiz AG
- United StatesPLUVICTONovartis Pharmaceuticals Corporation
- BelgiumPluvicto 1000 MBq/mlNovartis Europharm
- United KingdomPluvicto 7,400MBq/7.5-12.5ml solution for injection vialsNovartis Pharmaceuticals UK Ltd
- IrelandPluvicto 1000 MBq/mL solution for injection/infusionNovartis Europharm Limited
- NetherlandsPluvicto 1.000 MBq/ml oplossing voor injectie/infusieNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Pluvicto
- Norway · Pluvicto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6156dd33-b544-4fe0-9ad9-4d9bc0d17e7c GET /v1/drugs/6156dd33-b544-4fe0-9ad9-4d9bc0d17e7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf/innrennslislyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "V10XX04",
"marketed": false,
"strength": "1000 MBq/ml",
"ma_number": "EU/1/22/1703/001",
"substance": "Lutetium (177Lu) vipivotide tetraxetan",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44904"
}See everything about lutetium (177lu) oxodotreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.